This inventor holds 5 USPTO granted patents and 3 published patent applications. Top assignee: Inventisbio Co., Ltd.. Active years: 2023-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023-2025
Title: Innovations and Contributions of Inventor Liangshan Tao
Introduction
Liangshan Tao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of novel therapeutic agents. With a total of five patents to his name, his work focuses on innovative solutions for treating various diseases.
Latest Patents
Liangshan Tao's latest patents include groundbreaking research on C-terminal SRC kinase inhibitors. These novel inhibitors are designed to treat diseases such as cancer and to promote immune responses in patients. Additionally, he has developed thyroid hormone receptor agonists, which are aimed at addressing conditions like NAFLD, NASH, diabetes, hyperlipidemia, and hypercholesterolemia. His patents provide methods for preparing these compounds and utilizing them effectively in medical treatments.
Career Highlights
Throughout his career, Liangshan Tao has demonstrated a commitment to advancing medical science through his innovative inventions. His work has not only contributed to the understanding of complex biological processes but has also paved the way for new therapeutic strategies. His expertise in the field has made him a valuable asset to the scientific community.
Collaborations
Liangshan Tao collaborates with talented professionals in his field, including coworkers Yanqin Liu and Zhe Shi. These collaborations enhance the research and development process, allowing for a more comprehensive approach to innovation in biotechnology.
Conclusion
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile